• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制肾激肽释放酶对前列腺素E2、水和钠排泄的影响。

Effect of inhibiting renal kallikrein on prostaglandin E2, water, and sodium excretion.

作者信息

Saitoh S, Scicli A G, Peterson E, Carretero O A

机构信息

Department of Medicine, Henry Ford Hospital, Detroit, MI 48202-2689, USA.

出版信息

Hypertension. 1995 May;25(5):1008-13. doi: 10.1161/01.hyp.25.5.1008.

DOI:10.1161/01.hyp.25.5.1008
PMID:7737707
Abstract

To test the hypothesis that renal kinins act as natriuretic and diuretic hormones, we examined the effect of inhibiting glandular kallikrein on renal function in normotensive unanesthetized rats during normal sodium intake. To inhibit kallikrein at both the luminal and basolateral sides of the distal nephron, we used Fab fragments of monoclonal antibodies to rat urinary kallikrein (Fab-kallikrein). Fab fragments have advantages over intact IgG: they are filtered through the glomerulus and reach the lumen of the distal nephron, where kallikrein is localized and urinary kinins are released. Furthermore, the Fab fragment-antigen complex does not activate the complement system, avoiding the side effects associated with intact antibodies. Fab-kallikrein effectively blocked generation of kinins in the nephron lumen, decreasing urinary kininogenase activity (kallikrein) by 74% to 85% and kinin excretion by 76% to 79%. Fab-kallikrein induced a 30% decrease in urine volume and a 20% to 40% decrease in urinary sodium excretion but did not alter blood pressure, glomerular filtration rate, or renal blood flow. Although urinary prostaglandin E2 excretion also tended to decrease, this change was slower and of lesser magnitude than those of kinin and kininogenase excretion and did not attain statistical significance after Bonferroni's correction. In controls injected with either vehicle or Fab fragments of monoclonal antibodies to ricin (a vegetable protein not present in mammals), none of these parameters decreased significantly. We conclude that renal kinins participate in the short-term regulation of water and sodium excretion in normotensive unanesthetized rats, acting as diuretic and natriuretic hormones.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

为了验证肾激肽作为利钠和利尿激素的假说,我们研究了在正常钠摄入情况下,抑制腺激肽释放酶对正常血压未麻醉大鼠肾功能的影响。为了在远端肾单位的管腔侧和基底外侧侧均抑制激肽释放酶,我们使用了抗大鼠尿激肽释放酶单克隆抗体的Fab片段(Fab-激肽释放酶)。Fab片段比完整的IgG具有优势:它们可通过肾小球滤过并到达远端肾单位的管腔,激肽释放酶定位于此处且尿激肽在此处释放。此外,Fab片段-抗原复合物不会激活补体系统,避免了与完整抗体相关的副作用。Fab-激肽释放酶有效阻断了肾单位管腔内激肽的生成,使尿激肽原酶活性(激肽释放酶)降低74%至85%,激肽排泄降低76%至79%。Fab-激肽释放酶使尿量减少30%,尿钠排泄减少20%至40%,但未改变血压、肾小球滤过率或肾血流量。尽管尿前列腺素E2排泄也有下降趋势,但这种变化比激肽和激肽原酶排泄的变化更缓慢且幅度更小,经Bonferroni校正后未达到统计学显著性。在注射赋形剂或抗蓖麻毒素(一种哺乳动物中不存在的植物蛋白)单克隆抗体Fab片段的对照组中,这些参数均未显著降低。我们得出结论,肾激肽参与正常血压未麻醉大鼠水和钠排泄的短期调节,作为利尿和利钠激素发挥作用。(摘要截短至250字)

相似文献

1
Effect of inhibiting renal kallikrein on prostaglandin E2, water, and sodium excretion.抑制肾激肽释放酶对前列腺素E2、水和钠排泄的影响。
Hypertension. 1995 May;25(5):1008-13. doi: 10.1161/01.hyp.25.5.1008.
2
Renal effects of Fab fragments of kinin antibodies on deoxycorticosterone acetate-salt-treated rats.
Hypertension. 1990 Jun;15(6 Pt 2):761-6. doi: 10.1161/01.hyp.15.6.761.
3
Effect of pH and amiloride on the intrarenal formation of kinins.pH值和氨氯地平对肾内激肽形成的影响。
Am J Physiol. 1983 Aug;245(2):F198-203. doi: 10.1152/ajprenal.1983.245.2.F198.
4
Role of renal kallikrein in the increased fractional sodium excretion in the rat remnant kidney model of chronic renal failure.
Adv Exp Med Biol. 1989;247B:449-54. doi: 10.1007/978-1-4615-9546-5_74.
5
Antihypertensive and renal effects of captopril in spontaneously hypertensive rats: evidence against a role of the kallikrein-kinin system.卡托普利对自发性高血压大鼠的降压及肾脏效应:反对激肽释放酶-激肽系统起作用的证据
J Cardiovasc Pharmacol. 1987 Aug;10(2):222-7. doi: 10.1097/00005344-198708000-00013.
6
[Renal kallikrein-kinin system and control of blood pressure (author's transl)].肾激肽释放酶-激肽系统与血压调控(作者译)
Klin Wochenschr. 1979 Oct 1;57(19):1037-45. doi: 10.1007/BF01479989.
7
Renal kallikrein-kinin, prostaglandin E2, and dopamine systems in young normotensive subjects with a family history of essential hypertension.有原发性高血压家族史的年轻血压正常受试者的肾激肽释放酶-激肽、前列腺素E2和多巴胺系统
Am J Med Sci. 1994 Feb;307 Suppl 1:S70-4.
8
Interrelationships between the renal kallikrein-kinin and prostaglandin systems in furosemide-induced diuresis.速尿诱导利尿过程中肾脏激肽释放酶 - 激肽系统与前列腺素系统之间的相互关系。
Urol Int. 1984;39(1):52-7. doi: 10.1159/000280945.
9
The renal kallikrein-kinin system in human and in experimental hypertension.人类及实验性高血压中的肾激肽释放酶-激肽系统
Klin Wochenschr. 1978;56 Suppl 1:113-25. doi: 10.1007/BF01477462.
10
The relationship between kallikrein and water excretion and the conditional relationship between kallikrein and sodium excretion.激肽释放酶与水排泄之间的关系以及激肽释放酶与钠排泄之间的条件关系。
J Physiol. 1975 Apr;246(3):695-707. doi: 10.1113/jphysiol.1975.sp010911.

引用本文的文献

1
Bradykinin Stimulates Renal Na and K Excretion by Inhibiting the K Channel (Kir4.1) in the Distal Convoluted Tubule.缓激肽通过抑制远端卷曲小管中的钾通道(Kir4.1)刺激肾脏钠和钾的排泄。
Hypertension. 2018 Aug;72(2):361-369. doi: 10.1161/HYPERTENSIONAHA.118.11070. Epub 2018 Jun 18.
2
Direct regulation of ENaC by bradykinin in the distal nephron. Implications for renal sodium handling.远端肾单位中缓激肽对 ENaC 的直接调节。对肾脏钠处理的影响。
Curr Opin Nephrol Hypertens. 2014 Mar;23(2):122-9. doi: 10.1097/01.mnh.0000441053.81339.61.
3
The kallikrein-kinin system as a regulator of cardiovascular and renal function.
激肽释放酶-激肽系统作为心血管和肾功能的调节剂。
Compr Physiol. 2011 Apr;1(2):971-93. doi: 10.1002/cphy.c100053.
4
Blockade of renal medullary bradykinin B2 receptors increases tubular sodium reabsorption in rats fed a normal-salt diet.阻断肾髓质缓激肽B2受体可增加正常盐饮食喂养大鼠的肾小管钠重吸收。
Am J Physiol Renal Physiol. 2008 Sep;295(3):F811-7. doi: 10.1152/ajprenal.90225.2008. Epub 2008 Jul 16.
5
Vascular remodeling and the kallikrein-kinin system.血管重塑与激肽释放酶-激肽系统
J Clin Invest. 2005 Mar;115(3):588-91. doi: 10.1172/JCI24567.
6
Transgenic and knockout mice to study the renin-angiotensin system and other interacting vasoactive pathways.
Curr Hypertens Rep. 2000 Apr;2(2):211-6. doi: 10.1007/s11906-000-0084-1.
7
Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.血管紧张素转换酶抑制剂和血管紧张素II 1型受体拮抗剂对心力衰竭大鼠的影响。激肽和血管紧张素II 2型受体的作用。
J Clin Invest. 1997 Apr 15;99(8):1926-35. doi: 10.1172/JCI119360.
8
Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.缓激肽受体在清醒兔中血管紧张素转换酶及内肽酶24.11和24.15抑制的肾脏效应中的作用
Br J Pharmacol. 1996 Sep;119(2):365-73. doi: 10.1111/j.1476-5381.1996.tb15995.x.